Clinical Trial Update: REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study [Phase 4]

View source ↗

Summary

Phase 4 real-world prospective study evaluating mepolizumab in adults with severe asthma who achieved clinical remission on treatment; the trial is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Nucala (mepolizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: ACTIVE_NOT_RECRUITING